BerandaI9DN • FRA
add
Tekmira Pharmaceuticals
Tutup sebelumnya
€2,75
Rentang hari
€2,72 - €2,72
Rentang tahun
€2,52 - €4,22
Kapitalisasi pasar
589,90Â jt USD
Volume Rata-Rata
275,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,76Â jt | 15,14% |
Biaya operasional | 5,83Â jt | 9,79% |
Laba bersih | -24,53Â jt | -37,21% |
Margin laba bersih | -1,39Â rb | -19,16% |
Penghasilan per saham | -0,18 | -32,01% |
EBITDA | -12,68Â jt | 32,64% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 112,71Â jt | -12,79% |
Total aset | 117,01Â jt | -22,14% |
Total liabilitas | 37,85Â jt | 6,17% |
Total ekuitas | 79,16 jt | — |
Saham yang beredar | 191,50 jt | — |
Harga terhadap nilai buku | 6,71 | — |
Tingkat pengembalian aset | -26,19% | — |
Tingkat pengembalian modal | -34,60% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -24,53Â jt | -37,21% |
Kas dari operasi | -13,39Â jt | 30,60% |
Kas dari investasi | 11,35Â jt | -2,95% |
Kas dari pembiayaan | 2,78Â jt | -88,60% |
Perubahan kas bersih | 746,00Â rb | -95,56% |
Arus kas bebas | -3,83Â jt | 69,61% |
Tentang
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Didirikan
2007
Kantor pusat
Situs
Karyawan
44
